Opportunistic Osteoporosis Screening at Routine Abdominal and Thoracic CT: Normative L1 Trabecular Attenuation Values in More than 20 000 Adults.

Radiology

From the Department of Radiology, University of Wisconsin School of Medicine and Public Health, E3/311 Clinical Science Center, 600 Highland Ave, Madison, WI 53792-3252 (S.J., P.M.G., T.J.Z., S.J.L., P.J.P.); and Department of Diagnostic Radiology, National Institutes of Health Clinical Center, Bethesda, Md (R.M.S.).

Published: May 2019

Background Abdominal and thoracic CT provide a valuable opportunity for osteoporosis screening regardless of the clinical indication for imaging. Purpose To establish reference normative ranges for first lumbar vertebra (L1) trabecular attenuation values across all adult ages to measure bone mineral density (BMD) at routine CT. Materials and Methods Reference data were constructed from 20 374 abdominal and/or thoracic CT examinations performed at 120 kV. Data were derived from adults (mean age, 60 years ± 12 [standard deviation]; 56.1% [11 428 of 20 374] women). CT examinations were performed with ( = 4263) or without ( = 16 111) intravenous contrast agent administration for a variety of unrelated clinical indications between 2000 and 2018. L1 Hounsfield unit measurement was obtained either with a customized automated tool ( = 11 270) or manually by individual readers ( = 9104). The effects of patient age, sex, contrast agent, and manual region-of-interest versus fully automated L1 Hounsfield unit measurement were assessed using multivariable logistic regression analysis. Results Mean L1 attenuation decreased linearly with age at a rate of 2.5 HU per year, averaging 226 HU ± 44 for patients younger than 30 years and 89 HU ± 38 for patients 90 years or older. Women had a higher mean L1 attenuation compared with men ( < .008) until menopause, after which both groups had similar values. Administration of intravenous contrast agent resulted in negligible differences in mean L1 attenuation values except in patients younger than 40 years. The fully automated method resulted in measurements that were average 21 HU higher compared with manual measurement ( < .004); at intrapatient subanalysis, this difference was related to the level of transverse measurement used (midvertebra vs off-midline level). Conclusion Normative ranges of L1 vertebra trabecular attenuation were established across all adult ages, and these can serve as a quick reference at routine CT to identify adults with low bone mineral density who are at risk for osteoporosis. © RSNA, 2019 See also the editorial by Smith in this issue.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6492986PMC
http://dx.doi.org/10.1148/radiol.2019181648DOI Listing

Publication Analysis

Top Keywords

trabecular attenuation
12
attenuation values
12
contrast agent
12
osteoporosis screening
8
abdominal thoracic
8
normative ranges
8
vertebra trabecular
8
adult ages
8
bone mineral
8
mineral density
8

Similar Publications

Alleviating osteoarthritis-induced damage through extracellular vesicles derived from inflammatory chondrocytes.

Int Immunopharmacol

December 2024

Department of Joint Surgery & Sports Medicine, Zhongshan Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, Fujian 361004, China. Electronic address:

The role of extracellular vesicles (EVs) derived from inflammatory chondrocytes in EV-based therapy for osteoarthritis (OA) has received little attention. We examined the effects of EVs derived from both normal rat chondrocytes (nEVs) and IL-1β-treated rat chondrocytes (iEVs) on IL-1β-treated rat chondrocytes, macrophages, and osteoblasts, alongside mRNA-seq and miRNA-seq analyses of both them. Additionally, nEVs and iEVs were administered intra-articularly in the joints of rat models subjected to anterior cruciate ligament transection (ACLT), and the morphological alterations across the joints were assessed.

View Article and Find Full Text PDF

Isoginkgetin Inhibits RANKL-induced Osteoclastogenesis and Alleviates Bone Loss.

Biochem Pharmacol

January 2025

The Second Affiliated Hospital, Guangzhou Medical University, China; Guangzhou Medical University, China. Electronic address:

Osteoporosis is characterized by excessive osteoclast activity leading to bone loss, decreased bone mineral density, and increased susceptibility to fractures. Through in vivo/vitro experiments, along with network pharmacology analysis, we aimed to explore the underlying mechanisms of Isoginkgetin (IGG) in inhibiting osteoclastogenesis, providing valuable insights for further research in the future. Firstly, we ascertained the safe concentration of IGG stimulation on BMMs, followed by a systematic exploration of the concentration gradient at which IGG inhibited osteoclastogenesis using TRAP analysis.

View Article and Find Full Text PDF

Objective: To determine an optimal region of interest (ROI) for opportunistic screening of osteoporosis in terms of short-term in vivo diagnostic precision.

Materials And Methods: We included patients who underwent two CT scans and one dual-energy X-ray absorptiometry scan within a month in 2022. Deep-learning software automatically measured the attenuation in L1 using 54 ROIs (three slice thicknesses × six shapes × three intravertebral levels).

View Article and Find Full Text PDF

Entinostat treatment causes hypophosphatemia and hypocalcemia by increasing Fgf23 in mice.

Biochem Biophys Res Commun

December 2024

Institute of Orthopaedics, Suzhou Medical College, Soochow University, Suzhou 215006, China; Department of Orthopedics, The First Affiliated Hospital of Soochow University, Suzhou, 215006, China. Electronic address:

Article Synopsis
  • Entinostat, an HDACs-selective inhibitor being tested for cancer treatment, is linked to low phosphate and calcium levels during trials.
  • Research indicates that while Entinostat increases trabecular bone volume, it does not affect cortical bone strength or key bone-forming and resorbing cells.
  • The study highlights that Entinostat may elevate Fgf23 levels, leading to low phosphate and calcium, raising questions about its overall impact on bone health.
View Article and Find Full Text PDF

Matrix Gla protein suppresses osteoblast senescence and promotes osteogenic differentiation by the PI3K-AKT signaling pathway.

Exp Cell Res

January 2025

Department of Metabolism and Endocrinology, The Second Affiliated Hospital of Nanchang University, 330006, Nanchang, Jiangxi, China; Institute for the Study of Endocrinology and Metabolism in Jiangxi Province, Nanchang, 330006, China. Electronic address:

Article Synopsis
  • Age-related bone loss in mice is linked to the buildup of senescent cells and reduced bone formation by osteoblasts, highlighting the significance of Matrix Gla protein (MGP) in this process.
  • Researchers created a specific type of mouse (Mgp cKO) to investigate MGP's role in bone health, finding that these mice had decreased bone volume and increased markers of cellular damage and aging.
  • The study suggests that MGP helps protect against osteoblast aging, and introducing recombinant human MGP can enhance bone formation by activating a particular signaling pathway, pointing to new treatment options for osteoporosis.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!